Multifunctionality of PAI-1 in fibrogenesis:: Evidence from obstructive nephropathy in PAI-1-overexpressing mice

被引:117
作者
Matsuo, S
López-Guisa, JM
Cai, XH
Okamura, DM
Alpers, CE
Bumgarner, RE
Peters, MA
Zhang, GQ
Eddy, AA
机构
[1] Univ Washington, Dept Pediat, Seattle, WA 98105 USA
[2] Childrens Hosp & Reg Med Ctr, Seattle, WA 98105 USA
[3] Univ Washington, Dept Pathol, Seattle, WA 98105 USA
[4] Univ Washington, Dept Microbiol, Seattle, WA 98105 USA
关键词
interstitial fibrosis; plasminogen activator inhibitor-1; macrophage; urokinase; unilateral ureteral obstruction;
D O I
10.1111/j.1523-1755.2005.00327.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background. Plasminogen activator inhibitor-1 (PAI-1) has been implicated in the pathogenesis of chronic kidney disease based on its up-regulated expression and on the beneficial effects of PAI-1 inhibition or depletion in experimental models. PAI-1 is a multifunctional protein and the mechanisms that account for its profibrotic effects have not been fully elucidated. Methods. The present study was designed to investigate PAI-1-dependent fibrogenic pathways by comparing the unilateral ureteral obstruction model (UUO) (days 3, 7, and 14) in PAI-I-overexpressing mice (PAI-1 tg) to wild-type mice, both on a C57BL6 background. Results. Following UUO, total kidney PAI-1 mRNA and/or protein levels were significantly higher in the PAI-1 tg mice (N = 6 to 8/group) and fibrosis severity was significantly worse (days 3, 7, and 14), measured both as Sirius red-positive interstitial area (e.g., 10 +/- 3.2% vs. 4.5 +/- 1.0%) (day 14) and total kidney collagen (e.g., 11.1 +/- 1.7 vs. 6.2 +/- 1.3 mu g/mg) (day 14). By day 14, the expression of two normal tubular proteins, E-cadherin and Ksp-cadherin, were significantly lower in the PAI-1 tg mice (3.2 +/- 0.5% vs. 11.7 +/- 5.9% and 2.6 +/- 1.6) vs. 6.2 +/- 0.8%, respectively), implying more extensive tubular damage. At least four fibrogenic pathways were differentially expressed in the PAI-1 tg mice. First, interstitial macrophage recruitment was more intense (P < 0.05 days 3 and 14). Second, interstitial myofibroblast density was greater (P < 0.05 days 3 and 7) despite similar numbers of proliferating tubulointerstitial cells. Third, transforming growth factor-beta 1 (TGF-beta 1) and collagen I mRNA were significantly higher. Finally, urokinase activity was significantly lower (P < 0.05 days 7 and 14) despite similar mRNA levels. Gene microarray studies documented that that the deletion of this single profibrotic gene had far-reaching consequences on renal cellular responses to chronic injury. Conclusion. These data provide further evidence that PAI-1 is directly involved in interstitial fibrosis and tubular damage via two primary overlapping mechanisms: early effects on interstitial cell recruitment and late effects associated with decreased urokinase activity.
引用
收藏
页码:2221 / 2238
页数:18
相关论文
共 47 条
  • [21] MECHANISM OF PAI-1 ANTI-PROLIFERATIVE ACTIVITY TOWARDS LUNG AND PROSTATE CANCER CELLS
    Rozy, Adriana
    Kedzior, Marta
    Chorostowska-Wynimko, Joanna
    Jagus, Paulina
    Skronski, Michal
    Szpechcinski, Adam
    Skrzypczak-jankun, Ewa
    Jankun, Jerzy
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S716 - S717
  • [22] Elevated PAI-1 is associated with poor clinical outcomes in pediatric patients with acute lung injury
    Sapru, Anil
    Curley, Martha A. Q.
    Brady, Sandra
    Matthay, Michael A.
    Flori, Heidi
    INTENSIVE CARE MEDICINE, 2010, 36 (01) : 157 - 163
  • [23] SPECIFICITY OF ANTIGEN ASSAYS OF PLASMINOGEN-ACTIVATOR INHIBITOR IN PLASMA - INNOTEST PAI-1 IMMUNOASSAY EVALUATED
    MEIJER, P
    POLLET, DE
    WAUTERS, J
    KLUFT, C
    CLINICAL CHEMISTRY, 1994, 40 (01) : 110 - 115
  • [24] Targeting the PAI-1 Mechanism with a Small Peptide Increases the Efficacy of Alteplase in a Rabbit Model of Chronic Empyema
    Florova, Galina
    De Vera, Christian J.
    Emerine, Rebekah L.
    Girard, Rene A.
    Azghani, Ali O.
    Sarva, Krishna
    Jacob, Jincy
    Morris, Danna E.
    Chamiso, Mignote
    Idell, Steven
    Komissarov, Andrey A.
    PHARMACEUTICS, 2023, 15 (05)
  • [25] PAI-1 promotes the accumulation of exudate macrophages and worsens pulmonary fibrosis following type II alveolar epithelial cell injury
    Osterholzer, John J.
    Christensen, Paul J.
    Lama, Vibha
    Horowitz, Jeffrey C.
    Hattori, Noboru
    Subbotina, Natalya
    Cunningham, Andrew
    Lin, Yujing
    Murdock, Benjamin J.
    Morey, Roger E.
    Olszewski, Michal A.
    Lawrence, Daniel A.
    Simon, Richard H.
    Sisson, Thomas H.
    JOURNAL OF PATHOLOGY, 2012, 228 (02) : 170 - 180
  • [26] A 5-hydroxytryptamine receptor antagonist, sarpogrelate, reduces renal tubulointerstitial fibrosis by suppressing PAI-1
    Hamasaki, Yoshifumi
    Doi, Kent
    Maeda-Mamiya, Rui
    Ogasawara, Emi
    Katagiri, Daisuke
    Tanaka, Tamami
    Yamamoto, Tokunori
    Sugaya, Takeshi
    Nangaku, Masaomi
    Noiri, Eisei
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2013, 305 (12) : F1796 - F1803
  • [27] Increased PAI-1 in females compared with males is protective for abdominal aortic aneurysm formation in a rodent model
    DiMusto, Paul D.
    Lu, Guanyi
    Ghosh, Abhijit
    Roelofs, Karen J.
    Su, Gang
    Zhao, Yunge
    Lau, Christine L.
    Sadiq, Omar
    McEvoy, Brendan
    Laser, Adriana
    Diaz, Jose A.
    Wakefield, Thomas W.
    Henke, Peter K.
    Eliason, Jonathan L.
    Upchurch, Gilbert R., Jr.
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2012, 302 (07): : H1378 - H1386
  • [28] Feasibility of Measuring the Prognostic Factors uPA and PAI-1 in Core Needle Biopsy Breast Cancer Specimens
    Thomssen, Christoph
    Harbeck, Nadia
    Dittmer, Juergen
    Abraha-Spaeth, Shanti R.
    Papendick, Nancy
    Paradiso, Angelo
    Lisboa, Bjoern
    Jaenicke, Fritz
    Schmitt, Manfred
    Vetter, Martina
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2009, 101 (14) : 1028 - 1029
  • [29] UPA/PAI-1: a tool for breast cancer treatment individualization. Biology, clinical implications and quantification assays
    Lamy, P. -J.
    Romieu, G.
    Jacot, W.
    BULLETIN DU CANCER, 2010, 97 (03) : 341 - 348
  • [30] Role of plasminogen activator inhibitor-1 (PAI-1) in regulating the pathogenesis of S. aureus arthritis via plasminogen pathway
    Sultana, Sahin
    Dey, Rajen
    Bishayi, Biswadev
    IMMUNOLOGY LETTERS, 2019, 209 : 53 - 66